martes, 3 de marzo de 2009
Sueño o pesadilla: el juego a "futuras" alianzas...
Así titula Jack en Pharmagossip este complicado (y endogámico) diagrama de "especulaciones"...que toma de The New York Times
Dreaming up dream teams has become a popular sport since Pfizer, the world’s largest drug company, said it would buy Wyeth last month in a deal valued at $68 billion. Meanwhile, the big Swiss drug maker Roche is engaged in a hostile tender offer for the 44 percent of the American biotechnology company Genentech that it does not already own.
Etiquetas:
AZ,
BMS,
Glaxo,
J_J,
LCM(Life Cycle Management),
Merck,
Mergers,
Novartis,
Pfizer,
Roche,
SanofiAventis,
Schering Ploug,
Wyeth
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario